Purchase Order 75N95C25P00048
- Not listed
- On September 17, 2014, the National Center for Advancing Translational Sciences (NCATS) awarded a Blanket Purchase Agreement (BPA) call contract valued at $24,100.20 to Revvity Health Sciences, Inc., doing business as PerkinElmer Inc. This firm fixed-price contract was issued without a small business set-aside designation and is scheduled for completion by March 31, 2015. The work will be performed in Shelton, Connecticut. As a child entity of Revvity Inc., Revvity Health Sciences specializes in...
- This federal contract award was made by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.), a for-profit manufacturer and service provider of medical imaging products, laboratory equipment, and scientific instrumentation. The contract is for the provision of an "HTRF B-CATENIN TOTAL KIT - 10K PTS" and has a firm fixed price of $11,449.26. The contract does not have a set-aside...
- This is a firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.), a for-profit manufacturer of scientific and medical equipment. The contract is for the procurement of Streptavidin AlphaLISA Acceptor Beads and Protein A Alpha Donor Beads, with a ceiling value of $14,971.41 and a completion date of September 17, 2026. The contract does not have...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a firm-fixed price purchase order to Revvity Health Sciences, Inc. for the purchase of two reagent kits: the HTRF cAMP Gi Assay kit and the HTRF cAMP Gs Dynamic Assay kit. The total potential value of the award is $243,665.00. These kits will be used by NCATS' Tox21 group to screen a library of 10,000 compounds as part of a cross-partner project...
- On April 27, 2016, the National Center for Advancing Translational Sciences awarded a $22,206 firm fixed-price Blanket Purchase Agreement (BPA) call to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) for the acquisition of histone demethylases (KDM5A/KDM5B) kits to support ongoing project work for researchers Ajit Jadhav and S. Kales. The contract was completed by March 31, 2017, and performed at the contractor's facility in Shelton, Connecticut. No small business set-aside...
- Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) was awarded a Blanket Purchase Agreement (BPA) call valued at $3,656.64 by the National Cancer Institute on March 3, 2016, with an ultimate completion date of March 31, 2017. This firm fixed-price contract, issued without a small business set-aside, was performed in Bethesda, Maryland and represents a task order against a larger BPA vehicle. As a large business contractor, Revvity Health Sciences specializes in medical imaging...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $257,419.60 firm-fixed-price purchase order to Revvity Health Sciences, Inc. for the supply of a ViewLux HTS Imager from PerkinElmer Health Sciences Inc. This equipment will be used by the National Center for Advancing Translational Sciences (NCATS) to support its liquid dispensing high-throughput assays. The contract does not have a set-aside designation. Revvity Health Sciences,...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed-price purchase order to Revvity Health Sciences, Inc. for $20,685.50. The contract calls for Revvity to deliver 10,000 test kits of its proprietary Revvity HTRF SARS-CoV-2 capsid kit to the agency's specified delivery location in Rockville, Maryland by March 31, 2024. The solicitation sought this specific kit, which uses a homogeneous...
- The U.S. National Center for Advancing Translational Sciences (NCATS) awarded a $62,000 firm-fixed-price purchase order to Revvity Health Sciences, Inc. for the delivery of COVID-19 high throughput homogeneous assays for the detection of SARS-CoV-2 proteins in 384-well plates. This award, which did not utilize a set-aside, was made on April 15, 2020 with a completion date of October 31, 2020 under the Coronavirus COVID-19 national interest action. Revvity Health Sciences, Inc. is a subsidiary of...
- Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) was awarded a Blanket Purchase Agreement (BPA) call valued at $15,230.00 by the National Institute of Environmental Health Sciences on August 9, 2011, for Perkin Elmer Cyanine-3-CTP microarray supplies under a Firm Fixed Price contract type. The contract supported the Microarray Core facility's unmet needs for Fiscal Year 2011, with performance scheduled through March 31, 2012. The work was performed at the contractor's...
The National Center for Advancing Translational Sciences (NCATS) awarded a firm fixed-price purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) on April 11, 2025, for HTRF MAB Anti 6HIS-TB and Streptavidin-XLent reagents totaling 20,000 points, with a contract ceiling value of $12,440.16. The contract will be completed by April 6, 2026, with performance taking place in Hopkinton, Massachusetts. This procurement does not utilize a small business set-aside designation. HTRF (Homogeneous Time-Resolved Fluorescence) assay reagents and related scientific materials support NCATS' mission of advancing translational science and accelerating the development of medical therapeutics and diagnostics. Revvity Health Sciences is a large business contractor and established supplier of advanced scientific instrumentation and laboratory products to federal agencies across the research and medical sectors. The company maintains an extensive portfolio of federal contracts with agencies including the National Institutes of Health, Centers for Disease Control and Prevention, and Department of Veterans Affairs, providing specialized equipment, maintenance services, and scientific reagents. This purchase order represents a discrete procurement of specialized assay reagents supporting NCATS' translational research initiatives and the broader NIH research enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.4k | 4/11/25 |